- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 693613, 9 pages
Antioxidant and Hepatoprotective Effect of Aqueous Extract of Germinated and Fermented Mung Bean on Ethanol-Mediated Liver Damage
1Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2Department of Bioprocess Biotechnology, Malaysian Agriculture Research Development Institute, 43400 Serdang, Selangor, Malaysia
3Institute of Bioscience, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia
4Department of Bioprocess Technology, Faculty of Biotechnology and Biomolecular Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia
Received 30 August 2012; Revised 25 October 2012; Accepted 26 October 2012
Academic Editor: Andre Van Wijnen
Copyright © 2013 Norlaily Mohd Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mung bean is a hepatoprotective agent in dietary supplements. Fermentation and germination processes are well recognized to enhance the nutritional values especially the concentration of active compounds such as amino acids and GABA of various foods. In this study, antioxidant and hepatoprotective effects of freeze-dried mung bean and amino-acid- and GABA-enriched germinated and fermented mung bean aqueous extracts were compared. Liver superoxide dismutase (SOD), malondialdehyde (MDA), ferric reducing antioxidant power (FRAP), nitric oxide (NO) levels, and serum biochemical profile such as aspartate transaminase (AST), alanine transaminase (ALT), triglycerides (TG), and cholesterol and histopathological changes were examined for the antioxidant and hepatoprotective effects of these treatments. Germinated and fermented mung bean have recorded an increase of 27.9 and 7.3 times of GABA and 8.7 and 13.2 times of amino acid improvement, respectively, as compared to normal mung bean. Besides, improvement of antioxidant levels, serum markers, and NO level associated with better histopathological evaluation indicated that these extracts could promote effective recovery from hepatocyte damage. These results suggested that freeze-dried, germinated, and fermented mung bean aqueous extracts enriched with amino acids and GABA possessed better hepatoprotective effect as compared to normal mung bean.
Liver is a pivotal inflammatory organ that, involved in metabolism, storage, and excretion of metabolites. There are considerable numbers of hepatotoxins that have been reported to cause a liver damage such as ethanol, paracetamol, and carbon tetrachloride [1–5]. The mice model of liver injuries induced by various hepatotoxins showed similar trend but with slight variations such as increased membrane permeability, lipid peroxidation, and cell death which was comparable to development of chronic hepatic disease in humans. Upon stimulation from various hepatotoxins, Kupffer cells which release proinflammatory mediators such as NO and Interferon-gamma (IFN-γ) will eventually result in accumulation of reactive nitrogen species (ROS). ROS has been shown to cause lipid peroxidation and membrane degradation which will generate liver damage and inflammation [1, 3, 5, 6]. Natural sources of antioxidantssuch as green tea has been reported to increase the level of SOD and FRAP in cytoplasm of rat’s liver which reverted the injury effect close to normal . Polyphenols, flavonoids, and anthocyanins have been suggested to exert strong antioxidant activity, which contribute to the protective effect of against liver injury in rats [4, 7].
Mung bean (Vignaradiata), which is mainly cultivated in East Asia and South Asia regions contains rich source of protein, essential amino acids, minerals, vitamins, and fibers. It has been renowned of having multinutritional values as well as medicinal properties. Earlier studies have demonstrated that mung bean can act as an antioxidant [2, 8], liver protection  and antidiabetic agent due to its low glycemic index [10, 11]. Recently, it was reported that the ethanolic extract of mung bean exhibits antiinflammatory response by decreasing the proinflammatory cytokines in mouse macrophages [5, 12]. Germination and fermentation have been well associated with the elevated amount of antioxidants and GABA content [13–16]. GABA (γ-amino butyric acid) is a nonprotein amino acids that acts as a neuron inhibitors in mammals, which can be extracted from plant. Numerous studies have proclaimed that the roles of GABA as an antihypertension, anticancer, and antiinflammatory agents and its other healthful benefits [17–19]. These aspects have stimulated the interest to generate GABA-enriched natural products. Fermented soybean product, GABA-Tempeh, is a traditional food that contains abundance of oligopeptides and free amino acids (mainly GABA) which contribute to lower level of cholesterol in plasma . This effect can be correlated with liver function as lipid metabolism in body. Therefore, by undergoing germination and fermentation processes, freeze-dried mung bean aqueous extracts could contribute to liver protective effect and other healthful benefits. Wu et al.  were the first to report the hepatoprotective effects of mung bean. Their study compared the histological and biochemistry changes of acetaminophen-induced liver injury and the ameliorate properties of different Taiwan’s legumes such as adzuki bean, black bean, rice bean, and mung bean. Mung bean aqueous extract was identified to exhibit the best hepatoprotective effects among the legumes against liver injury agent, acetaminophen.
To date, no in vivo test has been conducted to assess the effect of freeze-driedgerminated and fermented mung bean aqueous extracts on animal model. The purposes of this study wereto compare the in vivo antioxidant enzymes content and hepatoprotective effects of freeze-dried normal mung bean, nutrient-enriched germinated, and fermented mung bean aqueous extracts on ethanol-induced liver damage mice model. This study also aimed to establish the correlation between the effects of fermentation and germination on amino acids and GABA level of mung bean and the hepatoprotective properties of the extracts.
2. Materials and Methods
Hypoxanthine, xanthine oxidase, superoxide dismutase, Folin-Ciocalteu reagent, aluminium chloride, sodium nitrate, ascorbic acid, and gallic acid were purchased from Sigma-Aldrich (USA). All solvents used were either of analytical reagent or HPLC grade. Griess reagent was from Invitrogen (USA). The Rhizopus sp. strain of 5351 inoculums was obtained from MARDI’s (Malaysian Agricultural Research and Development Institute) culture collection center. Milk thistle extracts containing 80% of silybin was obtained from Lipa Pharmaceutical Pty. Ltd. (Australia).
Male Balb/c mice of 8–10 weeks old weighing 20–25 g were maintained under standard condition of temperature (°C) and humidity in animal house with 12 h of light/dark cycle. Animals were provided with food and water ad libitum. Experiments were strictly conducted and approved by Animal Care and Use Committee, Universiti Putra Malaysia, (Ref: UPM/FPV/PS/184.108.40.2061/AUP-R2).
2.3. Plant Material
Mung bean (Vignaradiata) seeds were purchased from the local store in Selangor. The mung bean seeds were allowed to undergo solid-state fermentation base on our previous method  and germination process prior to extraction. For fermented mung bean , about 1000 g of dehulled mung bean seeds were soaked in cold water at room temperature for 18 h. Soaked mung beans were washed thoroughly and steamed for 40 minutes. After that, steamed seeds were cooled to room temperature and subsequently mixed with Rhizopus sp. strain of 5351 inoculums. From our previous preliminary studies (data not shown), mung bean seeds were screened with different Rhizopus sp. strains (5346, 5347, 5351, 5375, 5376, 5377, 5408, and 5410). The results revealed that Rhizopus sp. strain 5351 yielded the highest total amino acids and GABA content in fermented mung bean after 48 h of incubation at 30°C. Following this, the hepatoprotective effects of fermented mung bean inoculated with 5351 strain were evaluated. The inoculated beans were then packed into perforated plastics and incubated for 48 h at 30°C. Finally, all fermented mung bean seeds were dried and ground into powder prior to water extraction. On the other hand, germinated mung bean seeds was prepared by germinating the mung beans seeds inside the container Anaerocult A supplied with CO2 gas for up to 72 h. Germinated seeds were then allowed to dry until constant moisture content was obtained and ground into powder prior to water extraction. For control, mung bean seeds were directly ground into powder without prior fermentation or germination.
Finely ground powder was then extracted using deionised water (1 : 20 ratio) at 25°C for 30 minutes and placed in an incubator shaker at 300 rpm for 30 minutes under room temperature. Mixture was then centrifuged for 5 minutes at 10,000 rpm andthe supernatant was collected. Supernatants were furthersubjected to freeze-dry at operating temperature of −50°C (yield 25%, w/w). The freeze-dried powder was stored at 4°C. The assays were performed according to [20–22] with slight modifications.
2.3.1. GABA and Amino Acids Determination
The freeze-dried powder was dissolved in distilled water and filtered through 0.2 μm syringe filter prior to UPLC analysis. The derivatization process was done by mixing 70 μL of AccQ-Tag Ultra borate buffer with 10 μL of filtered extracts solution, followed by adding 20 μL of AccQ Fluor reagent in 1.5 mL eppendorf tube. All analyses were performed on a Waters Acquity UPLC system, comprised of a binary solvent manager, a sample manager fitted with 2 μL sample loop and UV-PDA detector set at 260 nm. The data were analyzed using Waters Empower 2 software. Acquity UPLC AccQ-Tag Ultra Column (2.1 mm i.d. × 100 mm × 1.7 μm particle size) was used for the determination of GABA and amino acids profile. The mobile phase used was AccQ-Tag Ultra Eluent A for mobile phase A and AccQ-Tag Ultra Eluent B for mobile phase B. The gradient condition was: 0–0.54 minutes, 0–0.1% B; 0.54–5.74 minutes, 0.1–9.1% B; 5.74–7.74 minutes, 9.1–21.2% B; 7.74–8.8 minutes, 21.2–59.6% B; 8.8–11 minutes, 59.6–0.1% B, and finally, reconditioning the column with 0.1% B with isocratic flow for 2.1 minutes after washing column with 59.6% B for 0.30 minutes. The flow rate was set at 0.7 mL/minutes and the injection volumes for all samples and standards were 1.0 μL. The column temperature was set at 55°C according to [20, 23].
2.4. In Vivo Hepatoprotective Effect-Ethanol Induced Hepatotoxicity in Mice
Total of 72 Balb/c mice were randomly distributed into eight groups (). Hepatoprotective effects of freeze-dried mung bean and fermented and germinated mung bean aqueous extracts were assessed in ethanol-induced liver damage animal model. Mice were pretreated orally with ethanol and plant aqueous extracts individually for up to 21 days. The experiment was designed as follows.
Group 1. Normal group, mice (p.o.) with 100 μL of normal saline for 14 days.
Group 2. Ethanol untreated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of 1 X PBS.
Group 3. Positive control group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of silybin (50 mg/kg).
Group 4. Low dose treated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of mung bean extract (200 mg/kg).
Group 5. High dose treated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of mung bean extract (1000 mg/kg).
Group 6. Low dose treated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of germinated mung bean extract (200 mg/kg).
Group 7. High dose treated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of germinated mung bean extract (1000 mg/kg).
Group 8. Low dose treated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of fermented mung bean extract (200 mg/kg).
Group 9. High dose treated group, mice (p.o.) with 100 μL of 50% (v/v) of ethanol for 7 days followed by 14 days of 100 μL of fermented mung bean extract (1000 mg/kg).
At the end of the experimental period, mice were sacrificed by cervical dislocation. Blood serum was obtained via cardiac puncture and subjected to serum biochemistry analysis and liver was immediately collected. Weight of liver was recorded and expressed as a relative organ weight .
2.5. Serum Biochemistry
Activities of blood serum marker enzyme including alanine transaminase (ALT), aspartate aminotransferase (AST), triglyceride (TG), and total cholesterol were measured using biochemical analyzer (Hitachi 902 Automatic Analyzer) and adapted reagents from Roche (Germany).
2.6. Liver Histopathological Evaluation
Liver was removed, fixed in 10% formalin solution, embedded in paraffin, sectioned into 4 microns thickness, and stained with haematoxylin and eosin (H&E) for assessment of histopathological alterations. Histopathological changes of stained livers were observed under bright-field microscope. Assessment of liver was graded based on vascular and necrotic changes according to . Vascular changes include vessel congestion, leakage of erythrocytes into surroundings, and hematoma formation. Necrotic changes show the appearance of necrosis, fibrosis, and cell regeneration. No change (no distinguishable change, 0%); mild change (30%); moderate change (31–60%); severe change (61–90%); very severe change (91–100%).
2.7. In Vitro Antioxidants of Liver Homogenate Evaluation
Mice liver were meshed in ice-cold PBS and homogenized before centrifuged at 2000 rpm for 5 minutes at 4°C. Supernatant was collected and subjected to different assays including superoxide dismutase (SOD) , malondialdehyde (MDA) , ferric reducing antioxidant power (FRAP)  and nitric oxide (NO) assay .
2.7.1. Determination of Superoxide Dismutase (SOD)
Briefly, SOD was determined following the method of evaluating the inhibition of the reduction of nitro blue tetrazolium (NBT) of liver homogenates. Briefly, sample was added with 0.1 mol/L EDTA, 0.15 mg/mL sodium cyanide, 1.5 mmol/L NBT, 0.12 mmol/L riboflavin, and 0.067 mol/L phosphate buffer to a final volume of 300 μL. The reduction was measured at 560 nm and percentage of SOD inhibition as compared to the blank was determined. One unit of SOD was calculated by the amount of protein needed to achieve the 50% inhibition and hence expressed as unit SOD/mg protein.
2.7.2. Determination of Malondialdehyde (MDA)
Liver peroxidation was detected by measuring thiobarbituric acid-reactive substance (TBARS). In brief, aliquot of 100 μL liver homogenate was diluted with 400 μL of PBS (8.1 g NaCl, 2.302 g Na2HPO4, and 0.194 g NaH2PO4/L) and mixed with 12.5 μL butyhydroxytoulene (BHT, 8.8 mg/mL) and 250 μL trichloroacetic acid (TCA, 30%). The mixture was vortexed and kept on ice for 2 h. Next, mixture was centrifuged at 2000 g for 15 min. Supernatant obtained was boiled for 15 min along with 37.5 μL 0.1 M EDTA and 125 μL thiobarbituric acid (TBA, 1%). After mixture has been cooled down to room temperature, the absorbance of pink-colored product was taken at 532 and 600 nm wavelength using ELISA Reader (Bio-tek Instrument, USA). The difference between absorbance was measured and compared to that of the standard malonaldehyde tetramethyl acetal solutions of different concentrations. MDA activity was expressed as nmol MDA/g protein.
2.7.3. Determination of Ferric Reducing Antioxidant Power (FRAP)
The FRAP was determined from reduction of Fe3+ to Fe2+ according to standard method with some modification. Reagent was prepared by mixing 300 mM acetate buffer (3.1 g C2H3NaO2·3H2O and 16 mL C2H4O2), 10 mM TPTZ (2, 4, 6-tripyridyl-s-triazine) solution, and 20 mM FeCl3·6H2O solution in 40 mM HCl. The fresh working solution was prepared by mixing 25 mL acetate buffer, 2.5 mL TPTZ solution, and 2.5 mL FeCl3·6H2O solution and then warmed at 37°C before using. Aliquot of 150 μL of bioactive extract (5 mg/mL) from mung bean, germinated, and fermented beans was allowed to react with 2850 μL of FRAP solution and shaken vigorously before being incubated in the dark for 30 min. The reading of the colored product (ferrous tripyridyltriazine complex) was taken at 593 nm. The FRAP activity was calculated from the standard FeSO4 calibration curve and FRAP value was expressed as μM Fe2+/mg protein.
2.7.4. Determination of Nitric Oxide
Briefly, NO production in liver was determined using a calorimetric Griess reaction (Invitrogen, USA). Liver homogenates (100 μL) was loaded onto microtitre plate, followed by 100 μL Griess reagent (1% sulphanilamide and 0.1% N-1-naphthylethylenediamine dihydrochloride in 2.5% polyphosphoric acid). Later, the absorbance was taken at 540 nm wavelength using ELISA Reader (Bio-tek Instrument, USA).
2.8. Statistical Analysis
All quantitative measurements were conveyed as mean ± SD Analyses were performed using one-way analysis of variance (ANOVA) and the group means were compared by Duncan test. was considered as statistically significant.
3.1. GABA and Amino Acids Content
We have previously reported that fermented mung bean contained 7.6 times and 13.2 times higher GABA and amino acids contents as compared to normal dried mung bean powder . Similarly, germinated mung bean also showed an increase in GABA and amino acids concentration by 27.9 times and 8.7 times to 0.502 ± 0.035 g/100 g and 2.092 ± 0.117 g/100 g of dried powder, respectively.
3.2. In Vivo Hepatoprotective Effect
3.2.1. Effect of Aqueous Extracts on Liver Function Biomarkers
ALT and AST are two biochemical markers normally used for early stage assessment of liver injury. Table 1 shows that ethanol had significantly raised serum ALT and AST level in mice liver as compared to normal group indicating the incident of liver injury. The serum ALT level was successfully brought down in all posttreatment groups with high doses of mung bean, germinated and fermented mung bean extracts (1000 mg/kg). In contrast, the serum ALT level in all low doses of mung bean extracts (200 mg/kg) treated groupswere continued to rise, indicating that the functions of liver have been compromised. In all extract-treated groups of both concentrations, the serum markers of AST were reduced to lower than the ethanol-attenuated group. Treatment with fermented mung bean at high dose (1000 mg/kg) displayed the highest suppression percentage of serumALT (63.73%) and AST (69.84%) followed by germinated mung bean high dose (1000 mg/kg), 45.25% (ALT) and 47.75% (AST), when compared to ethanol control group.
The above results showed that fermented mung beans at high dose (1000 mg/kg) were able to retain the serum ALT and AST closest to the normal level and has better performance than the standard drug, silybin.
3.2.2. Effect of Aqueous Extracts on Serum TG and Cholesterol
Another hallmark to confirm the acute alcohol-induced liver injury was indicated by elevated serum TG and cholesterol level. As shown in Table 1, treatment with extracts subsided the boosted level of TG and cholesterol with significant reduction in high dose fermented mung bean (1000 mg/kg) with 38.4% and 23.42%, respectively.
3.3. Effect of Aqueous Extracts on the Level of SOD, MDA, FRAP, and NO in Liver Homogenate
The effects of oral administration of mung bean, germinated, and fermented mung bean aqueous extracts on liver antioxidant were shown in Table 2. After being intoxicated with ethanol, a decline in the level of superoxide dismutase (SOD) and ferric reducing antioxidant power (FRAP) was observed in liver injury groups (ethanol-induced) when compared to normal group. Yet, SOD level increased back to normal in all extracts-treated mice with low (200 mg/kg/day) and high doses (1000 mg/kg/day) of mung bean, germinated, and fermented mung beans. On the other hand, MDA and NO levels were markedly increased in ethanol-attenuated liver, hallmarks of lipid peroxidation, and inflammatory response. Significant decrease in MDA and NO production were noticed in all aqueous extract-treated groups. Fermented mung bean was able to reduce MDA level by 3.6 times from 7.17 ± 0.17 to 2.00 ± 0.23 (nmol/g of protein) and NO level by 1.6 times from 14.72 ± 0.75 to 9.03 ± 0.06 (μmol/mg of protein). Meanwhile, it also elevated the SOD enzyme level and FRAP activity by 2.3 and 2.2 times, respectively, which essentially contribute to hepatoprotective effects against free radicals. Thehighest dose of fermented mung bean (1000 mg/kg/day) was found to be the most comparable to normal and standard drug silybingroups.
3.4. Histopathological Evaluation
Histopathology assessment of liver was performed for all groups. Figure 1(a) shows that there was no pathological abnormality observed in the liver of normal mice and thus showing the absence of vascular or necrosis changes. Figure 1(b) shows that ethanol induced severe necrosis changes and substantial changes in liver section such as ballooning, microvesicular steatosis, increase in sinusoidal space (SS) dilation and central vein, and lymphocytes cells infiltration in sinusoids in ethanol-untreated group as compared to normal group. The striking feature observed in ethanol-induced liver was in various stages of cytoplasmic condensation, microvesicular steatosis, and hepatocytes necrosis indicating early phases of liver injury. On the other hand, livers of mice in all aqueous extracts-treated groups showed noticeable recovery from ethanol-induced liver damage when compared to ethanol untreated group with less microvesicular steatosis and hepatocytes necrosis features. Moderate necrosis changes were noticed in all low doses of mung bean extracts-treated groups (Figures 1(d), 1(f), and 1(h)). The high dose of mung bean, germinated, and fermented mung bean aqueous extracts-treated groups illustrated mild necrosis and inflammatory changes, with less severity than changes observed after ethanol administration (Figures 1(e), 1(g), and 1(i)). Reduced degree of sinusoidal and central vein dilations, ballooning, and hepatocytes necrosis were noticed particularly in germinated and fermented mung beanat high dose (1000 mg/kg) (Figure 1(g)).
Ethanol has been reported as an eminent contributor to liver and kidney injury in humans and animals who have been exposed to excess ethanol for a certain period of time [1, 30]. Ethanol metabolism can trigger protein, lipid, and DNA degradation due to free radicalsformation. The result of the present study supports the work of previous published reports using natural extracts to treat ethanol-induced mice, as a model for acute liver disease [31, 32]. Features of ethanol-attenuated hepatocytes include inflammation, apoptosis, and necrosis including cirrhosis. In addition, prolonged exposure to ethanol has been shown to increase the level of TNF-α, a proinflammatory cytokines, which in turn can trigger other inflammatory chemokine, explicitly, NO. Decrease in antioxidant defense and elevation of serum markers such as AST, ALT, TG, and cholesterol were also observed [4, 33]. Furthermore, numerous studies have reported the association of antioxidant in the protection against oxidative liver injury [5, 34, 35].
To assess the hepatoprotective properties of extracts, in vivo study were performed to measure the serum markers and chemokine presence in it. According to Koch et al. , ethanol catabolism will result in surplus of NADH and acetyl-CoA thus causing lipogenesis of cholesterol and TG and also the leakage of cellular enzymes into plasma associated with serum ALT and AST. These will eventually contribute to liver injury. Thus, by restoring the level of serum ALT, AST, cholesterol, and TG back to normal, high dose of fermented mung beans has certified its hepatoprotective effects at least in part. Moreover, in the present study, hepatoprotective effects of mung bean was compared against germinated and fermented mung beans extracts. Higher degree of reduction in serum ALT, AST, cholesterol, and TG content were observed in germinated and fermented mung bean groups as compared to mung bean groups. Nonetheless, mung bean extracts also contributed to slight decline of those serum biomarkers. Our result was in agreement with previous works done on fermented food products where the induced serum markers were significantly restored back to normal through in vivo  and in vitro  studies.
The antioxidant properties of extracts were examined in mice liver tissue via MDA, SOD, FRAP, and NO assay. Increased amount of MDA in ethanol-induced liver signifies the enhance degree of lipid peroxidation, which can lead to liver damage. On contrary, SOD and FRAP levels in ethanol-induced group were decreased. A decrease in both activities in liver tissue of ethanol-induced group was largely due tothe impairment of antioxidant enzymes that safeguard cells against reactive oxygen species . On the other hand, increase in SOD and FRAP levels and decrease in MDA formation in fermented and germinated extracts-treated groups were as expected. High total phenolic content and strong antioxidant activity were claimed in fermented [37, 38] and germinated mung bean [14, 39]. This may be the reason for the increase of SOD and FRAP activities in germinated and fermented mung bean at high dose as compared to mung bean, which consequently reduced the MDA level. In addition, it has been reported that mung bean extract contains volatile antioxidant which was able to inhibit malonaldehyde formation in blood plasma .
NO is an inflammatory mediator and highly reactive oxidant produced by iNOS, which is released by kupffer cells upon exposure to hepatotoxins [5, 41]. In all extracts-treated groups, NO level was reverted to normal level. High dose fermented mung bean extracts were the most effective extracts to revert the elevation of NO level after induction with ethanol followed by germinated mung bean extracts. Thus, by suppressing NO production in liver, germinated and fermented mung beans depicted their potential properties as hepatoprotective agent.
A plausible justification for hepatoprotective and antioxidant effects of germinated and fermented mung beans at high dose may be due to the presence of flavonoids and phenolic acids bioactive compounds, which were highly detected particularly in fermented and germinated products [14, 42]. Besides, many studies have reported on the increased content of GABA and amino acids in commercial legumes after undergoing germination [43–46] and fermentation [21, 47] processes. Elevation of amino acids and GABA in our germinated and fermented mung bean extracts may be well added to liver protection properties since GABA amino acids have been known to carry liver protection through the mechanism of maintenance of intracellular polyamines levels of ethanol and CCl4-exposed hepatic injury effects [48, 49].
In the present study, histological evaluation was undertaken to support the biochemistry profiles. The pathological changes observed in the ethanol-treated liver through H&E staining were related to the results obtained. Administration of ethanol in mice animal model revealed that elevated level of liver function biomarkers ALT, AST, TG, and cholesterol levels were detected along with the decrease of antioxidant activity and severe necrosis histopathological changes. However, possible hepatoprotective effect of germinated and fermented mung bean extracts was observed when attenuated liver was treated with extracts. Previous study has reported the hepatoprotective properties of their extract to reduce microvesicular steatosis and hepatocytes necrosis in chronic liver injury, which is in agreement with our study . Liver injury hallmark such as inflammation, lymphocytes infiltration, necrosis and ballooning effects were restored back close to normal after administration of high dose of germinated and fermented mung bean extracts-treatment, supported by the decrease in ALT, AST, TG, cholesterol, NO, MDA and increase in FRAP and SOD activities. The correlation between liver biomarkers and histopathological changes suggested that they can be used for early detection of acute liver damage. Reduction of biochemical and histological damage was exerted by fermented and germinated mung bean, conforming their hepatoprotective properties.
No studies have been conducted on histopathological changes of fermented and germinated mung bean extracts on ethanol-attenuated liver. The biochemical and histopathological changes of attenuated liver after being treated with fermented and germinated mung bean were as expected since they contain more bioactive compounds compared to mung bean. Results prove that germinated and fermented mung bean exert better effects on liver injury than normal mung bean. This implies that the increase in amino acids, GABA, phenolic content, and other bioactives compounds during germination and fermentation processes contribute to the hepatoprotective effects of mung bean to ameliorate liver injury. Overall, fermented mung bean possessed the best antioxidant and hepatoprotective effect. This result gives us an idea that amino acid may play a more important role than GABA since we have observed better improvement of amino acid level in fermented than germinated mung bean but vice versa for GABA content.
To the best of our knowledge, no comparison studies have been made specifically between mung bean and germinated or fermented mung bean aqueous extracts in terms of their liver hepatoprotective and antioxidant enzyme properties. Freeze-dried fermented and germinated mung bean aqueous extracts at 1000 mg/kg body weight showed potential hepatoprotective effects on ethanol-induced liverinjury based on serum biochemical profile and histology evaluation of mice liver. This could be largely due to the amino acids content and antioxidant properties possessed by these extracts with regard to FRAP scavenging activity and oxidant-related factor, SOD. In conclusion, fermentation and germination increased the nutritional and medicinal values of mung bean. Moreover, the results are comparable with silybin, a standard drug typically prescribed to treat liver disease. Therefore, the results strongly imply the potential use of fermented and germinated mung bean aqueous extracts from natural product in future application for oxidative stress and liver disease therapy.
|GABA:||γ-amino butyric acid|
This project was funded by e-Science Fund under Ministry of Agriculture (MOA), Malaysia.
- M. M. Brzóska, J. Moniuszko-Jakoniuk, B. Piłat-Marcinkiewicz, and B. Sawicki, “Liver and kidney function and histology in rats exposed to cadmium and ethanol,” Alcohol and Alcoholism, vol. 38, no. 1, pp. 2–10, 2003.
- N. E. Rocha-Guzmán, A. Herzog, R. F. González-Laredo, F. J. Ibarra-Pérez, G. Zambrano-Galván, and J. A. Gallegos-Infante, “Antioxidant and antimutagenic activity of phenolic compounds in three different colour groups of common bean cultivars (Phaseolus vulgaris),” Food Chemistry, vol. 103, no. 2, pp. 521–527, 2007.
- U. S. Satyapal, V. J. Kadam, and R. Ghosh, “Hepatoprotective activity of livobond a polyherbal formulation against CCl4 induced hepatotoxicity in rats,” International Journal of Pharmacology, vol. 4, no. 6, pp. 472–476, 2008.
- V. R. L. López, G. S. Razzeto, M. S. Giménez, and N. L. Escudero, “Antioxidant properties of amaranthus hypochondriacus seeds and their effect on the liver of alcohol-treated rats,” Plant Foods for Human Nutrition, vol. 66, no. 2, pp. 157–162, 2011.
- G. J. Huang, J. S. Deng, S. S. Huang, Y. Y. Shao, C. C. Chen, and Y. H. Kuo, “Protective effect of antrosterol from Antrodia camphorata submerged whole broth against carbon tetrachloride-induced acute liver injury in mice,” Food Chemistry, vol. 132, no. 2, pp. 709–716, 2012.
- T. Liu, J. Zhao, L. Ma, Y. Ding, and D. Su, “Hepatoprotective effects of total triterpenoids and total flavonoids from Vitis vinifera L against immunological liver injury in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 969386, 8 pages, 2012.
- H. A. El-Beshbishy, O. M. Tork, M. F. El-Bab, and M. A. Autifi, “Antioxidant and antiapoptotic effects of green tea polyphenols against azathioprine-induced liver injury in rats,” Pathophysiology, vol. 18, no. 2, pp. 125–135, 2011.
- F. Lai, Q. Wen, L. Li, H. Wu, and X. Li, “Antioxidant activities of water-soluble polysaccharide extracted from mung bean (Vigna radiata L.) hull with ultrasonic assisted treatment,” Carbohydrate Polymers, vol. 81, no. 2, pp. 323–329, 2010.
- S. J. Wu, J. S. Wang, C. C. Lin, and C. H. Chang, “Evaluation of hepatoprotective activity of Legumes,” Phytomedicine, vol. 8, no. 3, pp. 213–219, 2001.
- Z. Madar and A. H. Stark, “New legume sources as therapeutic agents,” British Journal of Nutrition, vol. 88, no. 3, pp. S287–S292, 2002.
- Y. Yao, F. Chen, M. Wang, J. Wang, and G. Ren, “Antidiabetic activity of Mung bean extracts in diabetic KK-Ay mice,” Journal of Agricultural and Food Chemistry, vol. 56, no. 19, pp. 8869–8873, 2008.
- S. J. Lee, J. H. Lee, H. H. Lee et al., “Effect of mung bean ethanol extract on pro-inflammtory cytokines in LPS stimulated macrophages,” Food Science and Biotechnology, vol. 20, no. 2, pp. 519–524, 2011.
- M. J. R. Nout and J. L. Kiers, “Tempe fermentation, innovation and functionality: update into the third millenium,” Journal of Applied Microbiology, vol. 98, no. 4, pp. 789–805, 2005.
- R. Fernandez-Orozco, J. Frias, H. Zielinski, M. K. Piskula, H. Kozlowska, and C. Vidal-Valverde, “Kinetic study of the antioxidant compounds and antioxidant capacity during germination of Vigna radiata cv. emmerald, Glycine max cv. jutro and Glycine max cv. merit,” Food Chemistry, vol. 111, no. 3, pp. 622–630, 2008.
- Y. Z. Ding, S. Y. Zhang, P. Liu et al., “Microbiological and biochemical changes during processing of the traditional chinese food douzhi,” Food Control, vol. 20, no. 12, pp. 1086–1091, 2009.
- A. Matsuyama, K. Yoshimura, C. Shimizu, Y. Murano, H. Takeuchi, and M. Ishimoto, “Characterization of glutamate decarboxylase mediating γ-amino butyric acid increase in the early germination stage of soybean (Glycine max [L.] Merr),” Journal of Bioscience and Bioengineering, vol. 107, no. 5, pp. 538–543, 2009.
- C. H. Oh and S. H. Oh, “Effects of germinated brown rice extracts with enhanced levels of GABA on cancer cell proliferation and apoptosis,” Journal of Medicinal Food, vol. 7, no. 1, pp. 19–23, 2004.
- N. Watanabe, Y. Endo, K. Fujimoto, and H. Aoki, “Tempeh-like fermented soybean (GABA-tempeh) has an effective influence on lipid metabolism in rats,” Journal of Oleo Science, vol. 55, no. 8, pp. 391–396, 2006.
- Y. M. Kang, Z. J. Qian, B. J. Lee, and Y. M. Kim, “Protective effect of GABA-enriched fermented sea tangle against ethanol-induced cytotoxicity in HepG2 cells,” Biotechnology and Bioprocess Engineering, vol. 16, no. 5, pp. 966–970, 2011.
- S. K. Yeap, N. M. Ali, H. M. Yusof et al., “Antihyperglycemic effects of fermented and nonfermented mung bean extracts on alloxan induced-diabetic mice,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 285430, 7 pages, 2012.
- J. S. Tsai, Y. S. Lin, B. S. Pan, and T. J. Chen, “Antihypertensive peptides and γ-aminobutyric acid from prozyme 6 facilitated lactic acid bacteria fermentation of soymilk,” Process Biochemistry, vol. 41, no. 6, pp. 1282–1288, 2006.
- Y. Guo, H. Chen, Y. Song, and Z. Gu, “Effects of soaking and aeration treatment on γ-aminobutyric acid accumulation in germinated soybean (Glycine max L.),” European Food Research and Technology, vol. 232, no. 5, pp. 787–795, 2011.
- W. Liming, Z. Jinhui, X. Xiaofeng, L. Yi, and Z. Jing, “Fast determination of 26 amino acids and their content changes in royal jelly during storage using ultra-performance liquid chromatography,” Journal of Food Composition and Analysis, vol. 22, no. 3, pp. 242–249, 2009.
- S. Saravanan, B. N. Prakash, P. Pandikumar, R. M. Karunai, P. M. Gabriel, and S. Ignacimuthu, “Immunomodulatory potential of Enicostema axillare (Lam.) A. Raynal, a traditional medicinal plant,” Journal of Ethnopharmacology, vol. 140, no. 2, pp. 239–246, 2012.
- A. Y. L. Lim, I. Segarra, S. Chakravarthi, S. Akram, and J. P. Judson, “Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice,” BMC Pharmacology, vol. 10, no. 14, 2010.
- L. E. Ilouno, E. N. Shu, and G. E. Igbokwe, “An improved technique for the assay of red blood cell superoxide dismutase (SOD) activity,” Clinica Chimica Acta, vol. 247, no. 1-2, pp. 1–6, 1996.
- M. Suhail and M. Faizul-Suhail, “Oxidant-antioxidant status in pair-matched maternal and cord blood of normotensive and preeclamptic patients,” Journal of Chinese Clinical Medicine, vol. 4, no. 5, pp. 241–248, 2009.
- K. Thaipong, U. Boonprakob, K. Crosby, L. Cisneros-Zevallos, and D. Hawkins Byrne, “Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts,” Journal of Food Composition and Analysis, vol. 19, no. 6-7, pp. 669–675, 2006.
- R. R. He, B. Tsoi, F. Lan, N. Yao, X. S. Yao, and H. Kurihara, “Antioxidant properties of lutein contribute to the protection against lipopolysaccharide-induced uveitis in mice,” Chinese Medicine, vol. 6, no. 1, p. 38, 2011.
- P. Pramyothin, C. Ngamtin, S. Poungshompoo, and C. Chaichantipyuth, “Hepatoprotective activity of Phyllanthus amarus Schum. et. Thonn. extract in ethanol treated rats: in vitro and in vivo studies,” Journal of Ethnopharmacology, vol. 114, no. 2, pp. 169–173, 2007.
- J. Du, D. He, L. N. Sun et al., “Semen Hoveniae extract protects against acute alcohol-induced liver injury in mice,” Pharmaceutical Biology, vol. 48, no. 8, pp. 953–958, 2010.
- A. I. Ghoneim and O. A. Eldahshan, “Anti-apoptotic effects of tamarind leaves against ethanol-induced rat liver injury,” The Journal of Pharmacy and Pharmacology, vol. 64, no. 3, pp. 430–438, 2012.
- O. R. Koch, S. Fusco, S. C. Ranieri et al., “Role of the life span determinant P66shcA in ethanol-induced liver damage,” Laboratory Investigation, vol. 88, no. 7, pp. 750–760, 2008.
- A. Kshirsagar, A. Purnima, D. Ingawale, N. Vyawahare, K. Ingale, and A. Hadambar, “Antioxidant and hepatoprotective activity of Ethanolic extract of calotropis gigantea against Paracetamol induced liver damage in mice,” Journal of Cell and Tissue Research, vol. 9, no. 2, pp. 1859–1864, 2009.
- W. Zhao, J. J. Li, S. Q. Yue, L. Y. Zhang, and K. F. Dou, “Antioxidant activity and hepatoprotective effect of a polysaccharide from Bei Chaihu (Bupleurum chinense DC),” Carbohydrate Polymers, vol. 89, no. 2, pp. 448–452, 2012.
- Z. A. Zakaria, M. S. Rofiee, M. N. Somchit et al., “Hepatoprotective activity of dried- and fermented-processed virgin coconut oil,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 142739, 2011.
- S. L. Wang, Y. C. Liang, and T. W. Liang, “Purification and characterization of a novel alkali-stable α-amylase from Chryseobacterium taeanense TKU001, and application in antioxidant and prebiotic,” Process Biochemistry, vol. 46, no. 3, pp. 745–750, 2011.
- D. K. Kim, S. C. Jeong, S. Gorinstein, and S. U. Chon, “Total polyphenols, antioxidant and antiproliferative activities of different extracts in mungbean seeds and sprouts,” Plant Foods for Human Nutrition, vol. 67, no. 1, pp. 71–75, 2012.
- S. J. Lee and K. G. Lee, “Inhibitory effects of volatile antioxidants found in various beans on malonaldehyde formation in horse blood plasma,” Food and Chemical Toxicology, vol. 43, no. 4, pp. 515–520, 2005.
- N. Amat, H. Upur, and B. Blažeković, “In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 478–484, 2010.
- R. Randhir and K. Shetty, “Mung beans processed by solid-state bioconversion improves phenolic content and functionality relevant for diabetes and ulcer management,” Innovative Food Science and Emerging Technologies, vol. 8, no. 2, pp. 197–204, 2007.
- P. Sikiric, S. Seiwerth, Z. Grabarevic et al., “Hepatoprotective effect of BPC 157, a 15-aminoacid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCL4 administration. A comparative study with dopamine agonists and somatostatin,” Life Sciences, vol. 53, no. 18, pp. PL291–PL296, 1993.
- N. Komatsuzaki, K. Tsukahara, H. Toyoshima, T. Suzuki, N. Shimizu, and T. Kimura, “Effect of soaking and gaseous treatment on GABA content in germinated brown rice,” Journal of Food Engineering, vol. 78, no. 2, pp. 556–560, 2007.
- K. B. Park and S. H. Oh, “Production of yogurt with enhanced levels of gamma-aminobutyric acid and valuable nutrients using lactic acid bacteria and germinated soybean extract,” Bioresource Technology, vol. 98, no. 8, pp. 1675–1679, 2007.
- H. J. Chung, S. H. Jang, H. Y. Cho, and S. T. Lim, “Effects of steeping and anaerobic treatment on GABA (γ-aminobutyric acid) content in germinated waxy hull-less barley,” Food Science and Technology, vol. 42, no. 10, pp. 1712–1716, 2009.
- A. A. Khalil, “Nutritional improvement of an Egyptian breed of mung bean by probiotic lactobacilli,” African Journal of Biotechnology, vol. 5, no. 2, pp. 206–212, 2006.
- J. Y. Cha, J. J. Jeong, H. J. Yang, B. J. Lee, and Y. S. Cho, “Effect of fermented sea tangle on the alcohol dehydrogenase and acetaldehyde dehydrogenase in Saccharomyces cerevisiae,” Journal of Microbiology and Biotechnology, vol. 21, no. 8, pp. 791–795, 2011.
- T. Norikura, A. Kojima-Yuasa, D. Opare Kennedy, and I. Matsui-Yuasa, “Protective effect of gamma-aminobutyric acid (GABA) against cytotoxicity of ethanol in isolated rat hepatocytes involves modulations in cellular polyamine levels,” Amino Acids, vol. 32, no. 3, pp. 419–423, 2007.
- Y. H. Kuo, P. Rozan, F. Lambein, J. Frias, and C. Vidal-Valverde, “Effects of different germination conditions on the contents of free protein and non-protein amino acids of commercial legumes,” Food Chemistry, vol. 86, no. 4, pp. 537–545, 2004.